MN

Mekala Naga Malleswari

Active Director Director DIN 09847812
DIN 09847812 First appointment Jan 2023 Primary industry Research & Development
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jan 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Mekala Naga Malleswari

Data last updated:

Mekala Naga Malleswari is a Director at Pragnya Bioinnovations Private Limited (since 2023). The company operates in Research & Development.

DIN 09847812
Primary Designation Director
Industry Research & Development
First Appointment 03 Jan 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director03 Jan 20232023Active

Board colleagues of Mekala Naga Malleswari

NameDINCompanyDesignation
Janaki Ramaiah Mekala09847811Pragnya Bioinnovations Private LimitedDirector

Directorship timeline

Open interactive timeline →
Pragnya Bioinnovations Private Limited
Premium access

Shareholding and investment profile for Mekala Naga Malleswari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mekala Naga Malleswari

Mekala Naga Malleswari currently holds 1 directorship: Pragnya Bioinnovations Private Limited (Director, since 03 Jan 2023).

Mekala Naga Malleswari was first appointed on 03 Jan 2023 as Director at Pragnya Bioinnovations Private Limited.

The current boards of Mekala Naga Malleswari's companies include Janaki Ramaiah Mekala (Pragnya Bioinnovations Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available